(Q37000757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18001262%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Pregabalin in the management of central neuropathic pain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18001262%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18001262%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Paul Gray

series ordinal

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18001262%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18001262%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18001262%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18001262%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

3035-3041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18001262%20AND%20SRC:MED&resulttype=core&format=json

Anticonvulsants in central pain

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pharmacologic treatment of central post-stroke pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin for the treatment of painful neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin for the treatment of generalised anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin: in the treatment of painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin or morphine and gabapentin for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin: a new neuromodulator with broad therapeutic indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin pharmacology and its relevance to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

A treatment algorithm for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pain following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pain and syringomyelia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Incidence of central post-stroke pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Lamotrigine for central poststroke pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Central post-stroke pain syndrome: yet another use for gabapentin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Treatment of chronic neuropathic pain after traumatic central cervical cord lesion with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

A case of spinal cord injury-related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Gabapentin for neuropathic pain following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

A proposed algorithm for the management of pain following spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Development of a neuropathic pain questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Using screening tools to identify neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Antiepileptic drugs in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035

Pregabalin-withdrawal encephalopathy and splenial edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.17.3035